Drugs / HC106
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06738576 | Dec 2024 → Dec 2025 overdue | female stress incontinence | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HC106 | “expanded allogeneic mesenchymal stem cells derived from adipose tissue (HC106) for the treatment of urinary incontinence in women over 50 years of age.” NCT06738576 ↗ |
| Modality | Cell therapy | “expanded allogeneic mesenchymal stem cells derived from adipose tissue (HC106)” NCT06738576 ↗ |
| Route | Other | “Injection of the cell suspension” NCT06738576 ↗ |